New LDL cholesterol target ahead?

03/4/2013 | Nature (free content)

For the first time in a decade, the U.S. National Heart, Lung and Blood Institute is expected to reconsider its clinical guidelines for LDL cholesterol. Statins have been shown to lower the risk of cardiovascular events, but it has not been proven that reducing LDL with other pharmaceuticals has an impact, some cardiologists say. "We can't just assume that modifying the risk factor is modifying risk," says Harlan Krumholz of Yale University.

View Full Article in:

Nature (free content)

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Cargill
Wayzata, MN
Director of Clinical Research
Regenesis Biomedical, Inc.
Scottsdale, AZ
Actuary
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
MetLife
Bridgewater, NJ